NCT00820248 2023-08-22Radiation + Cisplatin or Panitumumab in Locally Advanced Stage III or Stage IV Head and Neck CancerCanadian Cancer Trials GroupPhase 3 Completed320 enrolled 13 charts
NCT03733210 2023-05-19Panitumumab-IRDye800 and 89Zr-Panitumumab in Identifying Metastatic Lymph Nodes in Patients With Squamous Cell Head and Neck CancerStanford UniversityPhase 1 Completed14 enrolled 12 charts
NCT00756444 2018-11-15A Randomized Phase 2 Pharmacokinetic Trial of Chemotherapy With or Without Panitumumab in Patients With Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and NeckAmgenPhase 2 Completed67 enrolled 8 charts